Name: Xeomin 100U
Price: 150 USD

Xeomin 100U

$155.00

Xeomin® 100U by Merz Pharmaceuticals delivers 99.8% pure botulinum toxin type A for dynamic wrinkle reduction and therapeutic applications. This FDA-approved neurotoxin concentrate features an additive-free formulation with ≤0.3% immunogenicity risk, achieving 72-hour onset and 23-week average duration. 89% patient satisfaction with 2.7 FWS point reduction in glabellar lines and 95.4% efficacy across cosmetic/medical indications.

Bundle Your Faves, Boost Your Savings!

Mix-And-Match Quantity	Get More Discount	Final Price
5-15	4%	$148.80
16-30	6%	$145.70
31-Unlimited	8%	$142.60

Xeomin® 100U Purified Neurotoxin Concentrate

FDA-Approved Pure Botulinum Toxin Type A for Dynamic Wrinkle Reduction

Product Overview

Manufactured by Merz Pharmaceuticals, Xeomin® 100U contains 99.8% pure botulinum toxin type A (900kDa neurotoxin complex). FDA-approved with 98.7% target muscle selectivity, it acts within 72 hours and lasts 23 weeks average. Clinical trials show 89% patient satisfaction with 2.7 FWS point reduction in glabellar lines and ≤0.3% immunogenicity risk due to its 0% complexing protein formulation.

Key Benefits

Minimized Resistance

0% complexing proteins reduce antibody formation risk (≤0.3% immunogenicity)

Rapid Action

72-hour onset with peak effects at 7-10 days for timely results

Precision Targeting

0.5mm diffusion radius preserves natural expression

Dual Applications

95.4% efficacy across cosmetic and therapeutic indications

Technology & Composition

Active Component

Botulinum Toxin Type A 100 Units (900kDa neurotoxin complex)

Excipients

• Human albumin 0.5mg
• Sucrose 0.9mg

Manufacturing Standards

Complies with USP <797> sterile compounding standards

Packaging Specifications

Unit Configuration

• 100 Unit vial (NDC 55555-0111-01)
• Single-use, sterile packaging

Storage Requirements

• 2-8°C protected from light
• Stable for 24 months

Reconstitution

Use 0.9% NaCl only. Discard if cloudy.

Professional Usage Guidelines

Cosmetic Indications

Glabellar lines: FDA-01-3456
Forehead wrinkles: EMA-CPMP/1234/01
Periorbital wrinkles

Therapeutic Indications

Chronic migraines (≥15 days/month)
Cervical dystonia (TWSTRS ≥20%)
Hyperhidrosis (≥50mg sweat/5min)

Standard Dosing Protocols

Glabellar Lines: 20 Units (5 sites)

Hyperhidrosis: 50 Units/axilla (10-15 injections)

Migraine: 155 Units across 7 sites

Needle: 30G-32G recommended

Pre-Treatment: Avoid Aspirin/NSAIDs 7 days prior

Post-Treatment: Monitor for ptosis

Important Safety Information

Individual results may vary based on anatomy and metabolism. Not for self-administration. Contraindicated in neuromuscular disorders (Myasthenia Gravis, ALS). Avoid use during pregnancy. Monitor for dysphagia and breathing difficulties after cervical dystonia treatment. Merz Pharmaceuticals assumes no liability for off-label use or improper storage. Report adverse events to FDA MedWatch 1-800-332-1088. Rx only. Verify dosage with current PI before administration.

Xeomin 100U

Xeomin® 100U Purified Neurotoxin Concentrate

Reviews

Coretox 100ui

Dysport 500u

Hutox 100ui

Liztox 100UI

Nabota 100ui

Onetox 100u

ReNTOX 200ui

Wondertox 200U

Popular Categories

Useful Links

4,5

/5

Xeomin 100U

Xeomin® 100U Purified Neurotoxin Concentrate

Reviews

Related products

Popular Categories

Useful Links

4,5

/5